a
Today's Top 20 StoriesRSS
NuVasive reported revenue growth in the fourth quarter and full year 2014 financial results. By Laura Dyrda -
ChoiceSpine appointed two new executives after acquiring the Baxano VEO Lateral Access & Interbody Fusion System. By Laura Dyrda -
PubMed Central will now include results from the International Journal of Spine Surgery, the journal of the International Society for the Advancement of Spine Surgery. By Laura Dyrda -

Improving patient value & outcomes 

Sponsored
Doctor Richard Kube and Vincent Zeringue discuss spinal stenosis market opportunity, disease state approach, and other topics for improving patient value and outcomes with effective MIS Spine Technology.  
Business philosophy is important for running a spine practice, but do you need an MBA to get there? By Laura Dyrda -
VertiFlex announced that the FDA's Orthopedic and Rehabilitation Devices Advisory Panel has voted in support of the premarket approval application for its Superion Interspinous Spacer System.  By Anuja Vaidya -
Brean Capital analyst Jason Wittes penned a glowing report on LDR, expecting growth in the future, according to a Benzinga report. By Laura Dyrda -
Integra LifeSciences reported revenue increase in the fourth quarter and full year of 2014, thanks in part to the company's neurosurgery and skin and wound businesses. By Laura Dyrda -
Spineology sued Wright Medical Technology, alleging the company's percutaneous expandable reamer infringed on an existing patent, according to a JDSUPRA Business Advisor report. By Laura Dyrda -
Both anterior cervical discectomy and fusion and posterior cervical foraminotomy are treatments for patients with cervical radiculopathy with similar outcomes. However, a new study seeks to determine whether their long-term reoperation rates could signify which procedure is better. By Laura Dyrda -
Amedica's stock price rose 23.08 percent last week, although the bid price remains under $1, which could be problematic for the company to remain listed, according to a Winston View report. By Laura Dyrda -
Aurora Spine completed the first trache of common share non-brokered private placement. By Laura Dyrda -
Can robots help surgeons treat spinal tumors? By Laura Dyrda -
The Nasdaq Listings Qualifications department sent Amedica a letter saying the minimum bid price per share for its common stock was below $1 for 30 consecutive business days, meaning the company didn't meet the minimum bid price required in the Nasdaq Listing Rule. By Laura Dyrda -
Orthopedic injuries are a hazard of the job for professional athletes. Yet, most athletes are able to undergo treatment — sometimes surgery — and then return to an elite level of play.  By Laura Dyrda -
Froedtert and the Medical College of Wisconsin Froedtert Hospital in Milwaukee became the next clinical site for InVivo Therapeutics' spinal cord injury treatment investigational device exemption clinical trial.  By Laura Dyrda -
Here is a snapshot of a physician in today's healthcare climate, according to A Survey of America’s Physicians in 2014: Practice Patterns and Perspectives.  By Anuja Vaidya -
Here are 18 key notes on spine and orthopedic device companies.  By Anuja Vaidya -
The spine surgeon's world is changing rapidly. As healthcare reform changes the landscape, surgeons are looking for the best way to spend their time and resources while optimizing their practices. By Laura Dyrda -
The minimally invasive surgical instruments market is poised for rapid growth in the coming years, according to a MarketsandMarkets.  By Anuja Vaidya -
Here are 11 orthopedic surgeons in the news over the past week. By Laura Dyrda -
Page 2 of 254